RxDoctor Payments DataLook up a doctor →

Kristi Hawley, DO

Dermatology · Caledonia, MINPI 1821350745

Payments from drug & device makers

$2,503,437in general payments, 2019–2025

Across 3,482 payments — averaging $718.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$448K
  • Sanofi$398K
  • AbbVie$342K
  • Sun Pharmaceutical Industries Inc.$193K
  • Arcutis Biotherapeutics, Inc.$149K
  • Eli Lilly$126K
  • plus $846K from 47 others
$47,239in research payments, 2019–2025

Across 12 payments — averaging $3936.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$37K
  • Eli Lilly$10K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.569$447,829
Sanofi312$398,297
AbbVie(2 entities)495$342,486
Sun Pharmaceutical Industries Inc.158$193,303
Arcutis Biotherapeutics, Inc.182$149,328
Eli Lilly14$126,351
Incyte Corporation191$120,123
Regeneron Healthcare Solutions, Inc.181$116,707
Novartis203$100,465
Amgen153$98,710
Galderma Laboratories, L.p.177$85,894
E.r. Squibb & Sons, L.L.C.134$74,924
Janssen Research & Development, LLC16$64,447
Bristol Myers Squibb56$43,513
Sanofi US Services Inc.14$36,085
Dermavant Sciences, Inc.52$32,768
Pfizer120$30,909
Kowa Pharmaceuticals America, Inc.8$10,989
Ortho Dermatologics, A Division Of Bausch Health US, LLC66$8,711
VYNE Pharmaceuticals Inc.71$6,893
Almirall LLC40$4,133
Johnson & Johnson90$3,128
LEO Pharma Inc.41$2,325
Helsinn Therapeutics (U.S.), Inc.1$1,455
Sanofi-aventis U.S. LLC9$647
Lilly USA, LLC27$468
Boehringer Ingelheim14$318
Organon13$305
Genentech USA, Inc.16$295
EPI Health, LLC10$259
Biofrontera Inc.3$194
Kyowa Kirin, Inc.8$177
Janssen Scientific Affairs, LLC2$121
Fresenius Kabi USA, LLC4$112
Merz North America, Inc.1$104
Journey Medical Corporation5$100
Mayne Pharma Commercial LLC5$84
Sensus Healthcare, Inc.1$82
Convatec Inc.2$74
Organogenesis Inc.2$58
Strata Skin Sciences, Inc.3$42
Myriad Genetic Laboratories, Inc.2$31
Nobelpharma America, LLC1$25
Paratek Pharmaceuticals, Inc.1$21
Alnylam Pharmaceuticals Inc.1$20
LNHC, Inc1$19
Biocon Biologics Inc1$19
Revance Therapeutics, Inc.1$16
Currax Pharmaceuticals LLC1$15
Verrica Pharmaceuticals Inc.1$15
Promius Pharma LLC1$15
Stemline Therapeutics Inc.1$15
Dermira, Inc.1$14

How this compares

$2,503,437 in reported general payments places this provider in the 95th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan →

Medicare billing

Part B allowed, 2024
$733,398
Medicare patients
193
Services billed
5,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Caledonia

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →